EURO-NMD is pleased to announce a new series of webinars focusing on Neuromuscular Junction Disorders (NMJ) — a group of rare but significant diseases affecting the communication between nerves and muscles.
This six-week series will feature internationally recognized experts sharing the latest developments in the field: from clinical evaluation and antibody testing to novel therapies and pediatric management. Each webinar will include a presentation followed by a Q&A session, providing participants with an opportunity to interact directly with the speakers.
All webinars will take place on Thursdays at 16:00–17:00 CET, except for one session on Wednesday 26 November, and are free to attend upon registration.
Programme
-
NMJ1 – How to Evaluate Patients with Myasthenia Gravis
Thursday 6 November 2025, 16:00–17:00 CET
Speakers: Dr. Lorenzo Maggi (Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy) & Lutgarde Allard (President of the European Myasthenia Gravis Association – EuMGA & Patient Expert)
Click here to watch the replay of the webinar!
-
NMJ2 – Update on Antibodies in Neuromuscular Junction Disorders
Thursday 20 November 2025, 16:00–17:00 CET
Speaker: Prof. Valentina Damato (University of Florence, Italy)
Click here to watch the replay of the webinar! (available soon)
-
NMJ3 – Innovative Therapies in Myasthenia Gravis
Wednesday 26 November 2025, 16:00–17:00 CET
Speaker: Prof. Dr. med. Andreas Meisel (Charité – Universitätsmedizin Berlin (CCM), Germany)
-
NMJ4 – Myasthenia Gravis in the Pediatric Age
Thursday 27 November 2025, 16:00–17:00 CET
Speaker: Dr. Adela Della Marina (University Hospital Essen, Germany)
-
NMJ5 – Update on Congenital Myasthenic Syndromes
Thursday 4 December 2025, 16:00–17:00 CET
Speaker: Prof. Hanns Lochmüller (Department of Neurology, Faculty of Medicine, University of Ottawa, Canada)
Join us for these insightful sessions to gain an updated overview of current research and management strategies in NMJ disorders, and to engage with colleagues and experts from across Europe!